Burn Degree Second: Clinical Trials

11 trials for Burn Degree Second, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 not yet recruiting, 2 unknown, 1 recruiting. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1
Phase 22Completed 1, Unknown 1
Early Phase 11Unknown 1
Phase 11Unknown 1
Phase 31Recruiting 1

Follow Burn Degree Second: new trials by email Literature Review of Burn Degree Second trials Research Report on Burn Degree Second

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients
Standard of Care (SOC) - Burn Degree Second, Burn Degree Third
Not yet recruitingUniversity Children's Hospital, Zurich2362026-12-012026-05-26
Phoenixin and Pain in Pediatric Burn Patients
Children, Acute Pain
Not yet recruitingAnkara City Hospital Bilkent872026-10-012026-10-05
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hyaluronate Carbomer Composite Hydrogel
sodium hyaluronate carbomer composite hydrogel - Burn, Burn Contracture of Skin
Not applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical College302026-08-152026-05-06
A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s)
PMS-101, Standard treatment - Burns, Burn Degree Second
Phase 1 / Phase 2UnknownPrimoris Therapeutics402025-01-012024-07-05
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
Skin Xenotransplant, Autograft(ing) - Burns Degree Third, Burn (Disorder)
Phase 3RecruitingXenoTherapeutics, Inc.502024-05-092025-04-02
Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients
Split-thickness skin graft, Artificial skin graft, Artificial skin graft co-culture - Burn Degree Second, Burn Degree Third
Early Phase 1UnknownUniversitas Indonesia202022-09-062022-12-15
Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients
Nefopam, Placebo (Vehicle) - Burn; Multiple Body Regions, Max. Second Degree, Third-Degree Burn
Phase 2CompletedUniversity of Alberta502022-07-102026-07-24
Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C
Vitamin C - Burns, Ascorbic Acid Deficiency
CompletedArrowhead Regional Medical Center542020-12-122022-11-10
The Effect of Reflexology Massage and Passive Music Therapy Intervention Before Burn Dressing
Reflexology massage, Reflexology massage and passive music - Burn Degree Second, Burn Degree Third
Not applicableCompletedSaglik Bilimleri Universitesi362019-08-122022-04-26
Predictive Mortality Scales in the Burn Patient Admitted to the Intensive Care Unit
Burn Any Degree Involving 20-29 Percent of Body Surface, Burn Any Degree Involving 30-39 Percent of Body Surface
CompletedUniversidad Rey Juan Carlos4652019-01-012026-04-13
The Treatment Challenges and Limitation in High-Voltage Pediatric Electrical Burn at Rural Area
Burns, Electrical Burn
CompletedS.K. Lerik General Hospital12017-08-072021-03-01

Narrower conditions

Burns (8)  ·  Pain (2)  ·  Acute Pain (1)  ·  Anxiety Disorders (1)  ·  Ascorbic Acid Deficiency (1)  ·  Burns, Electric (1)  ·  Cicatrix, Hypertrophic (1)

Broader conditions

Wounds and Injuries (8)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neurologic Manifestations (2)  ·  Signs and Symptoms (2)  ·  Avitaminosis (1)  ·  Cicatrix (1)  ·  Deficiency Diseases (1)  ·  Electric Injuries (1)  ·  Fibrosis (1)  ·  Malnutrition (1)  ·  Mental Disorders (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)

Interventions

Ascorbic Acid (1)  ·  Musculoskeletal Manipulations (1)  ·  Nefopam (1)  ·  Standard of Care (1)

Sponsors

Ankara City Hospital Bilkent (1)  ·  Arrowhead Regional Medical Center (1)  ·  Primoris Therapeutics (1)  ·  S.K. Lerik General Hospital (1)  ·  Saglik Bilimleri Universitesi (1)  ·  The First Affiliated Hospital of Xinxiang Medical College (1)  ·  Universidad Rey Juan Carlos (1)  ·  Universitas Indonesia (1)  ·  University Children's Hospital, Zurich (1)  ·  University of Alberta (1)  ·  XenoTherapeutics, Inc. (1)

Countries

Indonesia (2)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Adi Basuki, MD (1)  ·  Aldin Malkoc, MD (1)  ·  Bounthavy Homsombath, MD (1)  ·  David T Wong, MD (1)  ·  Edward E Tredget, MD (1)  ·  Joanneke Joanneke, Dr (1)

Results publications

PMID 40407357, PMID 8300697

NIH funding

2025 (1)